BIAFW
bioAffinity Technologies, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$0.45
+42.86%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.22x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.13x
- Price / sales
- 0.08x
- Price / cash flow
- -0.04x
Enterprise value
- Enterprise value
- -$514.9K
- EV / sales
- -0.09x
- EV / EBITDA
- 0.03x
- EV / EBIT
- 0.04x
- Market cap
- $479.9K
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026